Related references
Note: Only part of the references are listed.MicroRNA-494 Within an Oncogenic MicroRNA Megacluster Regulates G1/S Transition in Liver Tumorigenesis Through Suppression of Mutated in Colorectal Cancer
Lionel Lim et al.
HEPATOLOGY (2014)
MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression
Kai Zhu et al.
CARCINOGENESIS (2013)
Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma
Rongrong Wei et al.
CLINICAL CANCER RESEARCH (2013)
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
Hongping Xia et al.
HEPATOLOGY (2013)
miR-126&126*Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma
Nadia Felli et al.
PLOS ONE (2013)
Plasma microRNA profile as a predictor of early virological response to interferon treatment in chronic hepatitis B patients
Xiaonan Zhang et al.
ANTIVIRAL THERAPY (2012)
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma
Nicola Personeni et al.
JOURNAL OF HEPATOLOGY (2012)
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
Nicole Grabinski et al.
MOLECULAR CANCER (2012)
DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways
Ioannis S. Vlachos et al.
NUCLEIC ACIDS RESEARCH (2012)
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression
A. Petrelli et al.
ONCOGENE (2012)
Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma
Ya-Hui Huang et al.
PLOS ONE (2012)
Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
Jin Hou et al.
CANCER CELL (2011)
MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
Sara Toffanin et al.
GASTROENTEROLOGY (2011)
Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2011)
The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2
Carmen Chak-Lui Wong et al.
GASTROENTEROLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16INK4A
Fei-Fei Lan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma
Dong Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Underexpressed microRNA-199b-5p targets Hypoxia-Inducible Factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients
Chuanxi Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer
C. Braconi et al.
ONCOGENE (2011)
Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib
Giovanni Abbadessa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines
Jon C. Henry et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
Francesca Fornari et al.
CANCER RESEARCH (2010)
A Meta-Analysis of Survival Rates of Untreated Patients in Randomized Clinical Trials of Hepatocellular Carcinoma
Giuseppe Cabibbo et al.
HEPATOLOGY (2010)
Curcumin blocks migration and invasion of mouse-rat hybrid retina ganglion cells (N18) through the inhibition of MMP-2,-9, FAK, Rho A and Rock-1 gene expression
Hui-Ju Lin et al.
ONCOLOGY REPORTS (2010)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated
Xiao-Hui Huang et al.
HEPATOLOGY RESEARCH (2009)
Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis
Marcus Alexander Wörns et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
Georgia Sotiropoulou et al.
RNA (2009)
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype
Erin Connolly et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival
Jinmai Jiang et al.
CLINICAL CANCER RESEARCH (2008)
Evaluation and validation of total RNA extraction methods for MicroRNA expression analyses in formalin-fixed, paraffin-embedded tissues
Martina Doleshal et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
Alejandro Forner et al.
HEPATOLOGY (2008)
Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies
Jessica Zucnan-Rossi et al.
PHARMACOGENOMICS (2007)
Cyclin g1 is a target of miR-122a, a MicroRNA frequently down-regulated in human hepatocellular carcinoma
Laura Gramantieri et al.
CANCER RESEARCH (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues
Y Murakami et al.
ONCOGENE (2006)
Increasing hepatitis C virus-associated hepatocellular carcinoma mortality and aging: Long term trends in Japan
N Taura et al.
HEPATOLOGY RESEARCH (2006)
Dysregulation of growth factor signaling in human hepatocellular carcinoma
K. Breuhahn et al.
ONCOGENE (2006)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Image-guided tumor ablation: Proposal for standardization of terms and reporting criteria
SN Goldberg et al.
RADIOLOGY (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Transforming growth factor β and the liver
DM Bissell et al.
HEPATOLOGY (2001)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
Y Ito et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
